Postmastectomy Reconstruction Outcomes After Intraoperative Evaluation with Indocyanine Green Angiography Versus Clinical Assessment
- 461 Downloads
Mastectomy flap necrosis is a major complication in patients undergoing tissue expander-based reconstruction. This study compared the complication rates following mastectomy and immediate reconstruction with intraoperative indocyanine green (ICG) angiography evaluation to those with clinical assessment only.
We performed a single-institution retrospective study of mastectomy patients who underwent immediate tissue expander-based reconstruction between September 2009 and December 2013. ICG angiography was adopted in March 2012. The rates of complications in the ICG and clinical assessment only groups were compared. Factors associated with complications were identified with the Fischer exact test and univariate analysis.
A total of 114 patients were identified; clinical assessment only, 53 patients; ICG angiography, 61 patients. The overall complication rates were not significantly different between the two groups (ICG angiography, 50.8 %; clinical assessment, 43.4 %; p = 0.46). There was no significant difference in the rates of unexpected return to the operating room, cellulitis, hematomas, and seromas. The overall rates of flap necrosis were not significantly different (ICG angiography, 27.9 %; clinical assessment, 18.9 %; p = 0.28). However, the rates of severe flap necrosis were significantly lower with intraoperative ICG angiography (4.9 %) than with clinical assessment only (18.9 %, p = 0.02). On univariate analysis, breast weight (≥500 g) was significantly associated with increased rates of severe flap necrosis (p = 0.04), whereas body mass index, age, smoking status, prior breast surgery, history of radiation therapy, and receipt of nipple-sparing mastectomy were not.
We observed that the implementation of intraoperative ICG angiography was associated with a significant decrease in the rate of severe flap necrosis.
KeywordsTissue Expander Flap Necrosis Necrosis Rate Tumescent Solution Comparative Outcome Study
Dr. Cunningham is a consultant for LifeCell Corp and Mentor Corp
- 1.American Society of Plastic Surgeons (2014). Plastic Surgery Statistics Report. ASPS National Clearinghouse of Plastic Surgery Procedural Statistics. Available at: http://www.plasticsurgery.org/Documents/news-resources/statistics/2014-statistics/plastic-surgery-statsitics-full-report. Accessed 1 Feb 2016.
- 5.Newman MI, Samson MC, Tamburrino JF, Swartz KA, Brunworth L: An investigation of the application of laser-assisted indocyanine green fluorescent dye angiography in pedicle transverse rectus abdominus myocutaneous breast reconstruction. Can J Plast Surg. 2011;19:e1–e5.PubMedPubMedCentralGoogle Scholar
- 13.Reuthebuch O, Haussler A, Genoni M, et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest. 2004;125(2):418e24.Google Scholar
- 16.Munabi NC, Olorunnipa OB, Goltsman D, Rohde CH, Ascherman JA. The ability of intra-operative perfusion mapping with laser-assisted indocyanine green angiography to predict mastectomy flap necrosis in breast reconstruction: a prospective trial. J Plast Reconstr Aesthet Surg. 2014;67(4):449–55.CrossRefPubMedGoogle Scholar
- 18.Centers for Disease Control and Prevention. Surgical Site Infection (SSI) Event (January 2016). National Healthcare Safety Network. Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent. Accessed 1 Feb 2016.
- 19.Harless CA, Jacobson SR. Tailoring through technology: a retrospective review of a single surgeon’s experience with implant-based breast reconstruction before and after implementation of laser-assisted indocyanine green angiography [published online February 21 2016]. Breast J. 2016. doi: 10.1111/tbj.12576 PubMedGoogle Scholar
- 30.Seth AK, Hirsch EM, Fine NA, et al. Additive risk of tumescent technique in patients undergoing mastectomy with immediate reconstruction. Ann Surg Oncol. 2011;3041–6.Google Scholar